Long-Term Study Suggests Extended Relief from Atopic Dermatitis After Topical Treatment
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Researchers evaluated a proprietary dual hyaluronic acid complex designed to promote tissue remodeling through biomaterial-based regenerative biostimulation rather than localized inflammation.